-mediated energy preservation and axon protection during but not prior to energy deprivation. NMNAT catalyzes the reversible reaction that produces nicotinamide adenine dinucleotide (NAD) from nicotinamide mononucleotide (NMN). Interestingly, preventing the production of NAD from NMN with FK866 increased [ATP] axon and protected axons from energy deprivation. These results indicate that the Wld S mutation depends on its intrinsic Wld S NMNAT activity and the subsequent increase in axon ATP but not NAD to protect axons, implicating a novel role of Wld S NMNAT in axon bioenergetics and protection.
Wld
S mutation protects axons from degeneration in diverse experimental models of neurological disorders, suggesting that the mutation might act on a key step shared by different axon degeneration pathways. Here we test the hypothesis that Wld S protects axons by preventing energy deficiency commonly encountered in many diseases. We subjected compartmentally cultured, mouse cortical axons to energy deprivation with 6 mM azide and zero glucose. In wild-type (WT) culture, the treatment, which reduced axon ATP level ([ATP] , 2006; Gillingwater et al., 2006) , and motor neuron disease (Ferri et al., 2003) . Understanding the mechanisms of Wld S -mediated axon protection may reveal invaluable insights into the mechanism of axon injury and provide a basis for new treatments for neurological disorders associated with axon degeneration.
The Wld S mutation is a spontaneous 85-kb tandem triplication (Coleman et al., 1998) , which encodes a chimeric protein composed of the N-terminal 70 amino acids of ubiquitination factor Ube4b, a short junction sequence, and the full length of nicotinamide mononucleotide adenylyltransferase 1 (NMNAT1; Mack et al., 2001) . NMNAT catalyzes the reversible reaction that produces nicotinamide adenine dinucleotide (NAD) and pyrophosphate (PPi) from ATP and nicotinamide mononucleotide (NMN) in the forward mode or creates ATP and NMN from NAD and PPi in the reverse mode (Lau et al., 2009 ).
There is compelling evidence indicating that NMNAT activity is required for Wld S -mediated axon protection (Araki et al., 2004; Avery et al., 2009; Conforti et al., 2009; Yahata et al., 2009) . NAD, the product of NMNAT forward reaction, as well as many components in the NAD biosynthetic pathway have also been reported to be axon-protective (Sasaki et al., 2006; Wang et al., 2005 
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